Impact of diagnostic labels and management benefit-to-harms information for low-risk prostate pathology

Bell KJL, Boroumand F, Wu Z, Wilt TJ, Parker L, Millar J, Smith J, McCaffery K, Brodersen JB, Dahm P, Delahunt B, Glasziou P, Warden A, Diller L, van Rensburg C, Nickel B.